Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells

Immunology

Volumn 118, Issue 3, 2006, Pages 311-320

  George Chandy, Annie ^a   Hultkrantz, Susanne ^b   Raghavan, Sukanya ^a   Czerkinsky, Cecil ^c   Lebens, Michael ^a   Telemo, Esbjörn ^b   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c International Vaccine Institute   (South Korea)

Author keywords

Cholera toxin; Cholera toxin B subunit; Oral tolerance; Regulatory T cells

Indexed keywords

AUTOANTIGEN; CHOLERA TOXIN B SUBUNIT; HEMAGGLUTININ; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOTHELIUM; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHOLERA TOXIN; DOWN-REGULATION; HEMAGGLUTININS, VIRAL; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTEGRINS; L-SELECTIN; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-2; SPLEEN; T-LYMPHOCYTE SUBSETS; UP-REGULATION;

EID: 33745209642     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02368.x     Document Type: Article

References (45)

1. Bergerot I Ploix C Petersen J et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 1997 94 ( 9 4610 4.
2. Sun JB Rask C Olsson T Holmgren J Czerkinsky C. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 1996 93 ( 14 7196 201.
3. Tarkowski A Sun JB Holmdahl R Holmgren J Czerkinsky C. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum 1999 42 ( 8 1628 34.
4. Wiedermann U Jahn-Schmid B Lindblad M Rask C Holmgren J Kraft D Ebner C. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int Immunol 1999 11 ( 10 1717 24.
5. Rask C Holmgren J Fredriksson M Lindblad M Nordstrom I Sun JB Czerkinsky C. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin Exp Allergy 2000 30 ( 7 1024 32.
6. Tamura S Hatori E Tsuruhara T Aizawa C Kurata T. Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 1997 15 ( 2 225 9.
7. Sun JB Mielcarek N Lakew M Grzych JM Capron A Holmgren J Czerkinsky C. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. J Immunol 1999 163 ( 2 1045 52.
8. McSorley SJ Rask C Pichot R Julia V Czerkinsky C Glaichenhaus N. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur J Immunol 1998 28 ( 2 424 32.
9. Garside P Mowat AM. Oral tolerance. Semin Immunol 2001 13 ( 3 177 85.
10. Lundin BS Karlsson MR Svensson LA Hanson LA Dahlgren UI Telemo E. Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes. Clin Exp Immunol 1999 116 ( 1 181 7.
11. Marth T Ring S Schulte D Klensch N Strober W Kelsall BL Stallmach A Zeitz M. Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice. Eur J Immunol 2000 30 ( 12 3478 86.
12. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001 182 : 18 32.
13. Bluestone JA Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003 3 ( 3 253 7.
14. Roncarolo MG Bacchetta R Bordignon C Narula S Levings MK. Type 1 T regulatory cells. Immunol Rev 2001 182 : 68 79.
15. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997 18 ( 7 335 43.
16. Freytag LC Clements JD. Mucosal adjuvants. Vaccine 2005 23 ( 15 1804 13.
17. Kearney ER Pape KA Loh DY Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994 1 ( 4 327 39.
18. + single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 1994 180 ( 1 25 34.
19. George-Chandy A Eriksson K Lebens M Nordstrom I Schon E Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 2001 69 ( 9 5716 25.
20. Svennerholm AM Wikstrom M Lindblad M Holmgren J. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins. neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med Biol 1986 64 ( 1 23 30.
21. Lyons AB Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994 171 ( 1 131 7.
22. Sun JB Holmgren J Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 1994 91 ( 23 10795 9.
23. Hultkrantz S Ostman S Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology 2005 116 ( 3 362 72.
24. + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001 167 ( 1 188 95.
25. Boussiotis VA Freeman GJ Gray G Gribben J Nadler LM. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993 178 ( 5 1753 63.
26. Karlsson M Lundin S Dahlgren U Kahu H Pettersson I Telemo E. 'Tolerosomes' are produced by intestinal epithelial cells. Eur J Immunol 2001 31 ( 10 2892 900.
27. Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T (R) 1 and T (H) 3 regulatory cells. Nat Immunol 2001 2 ( 8 671 2.
28. Chen Y Inobe J Weiner HL. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell Immunol 1997 178 ( 1 62 8.
29. Sun J Dirden-Kramer B Ito K Ernst PB Van Houten N. Antigen-specific T cell activation and proliferation during oral tolerance induction. J Immunol 1999 162 ( 10 5868 75.
30. Kobets N Kennedy K O'Donnell D Garside P. An investigation of the ability of orally primed and tolerised T cells to help B cells upon mucosal challenge. Immunology 2004 112 ( 4 550 8.
31. Samsom JN Hauet-Broere F Unger WW La VANB Kraal G. Early events in antigen-specific regulatory T cell induction via nasal and oral mucosa. Ann N Y Acad Sci 2004 1029 : 385 9.
32. Spahn TW Fontana A Faria AM et al. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol 2001 31 ( 4 1278 87.
33. Spahn TW Weiner HL Rennert PD Lugering N Fontana A Domschke W Kucharzik T. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002 32 ( 4 1109 13.
34. Kunkel D Kirchhoff D Nishikawa S Radbruch A Scheffold A. Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice. Eur J Immunol 2003 33 ( 5 1292 301.
35. Kantele A Zivny J Hakkinen M Elson CO Mestecky J. Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol 1999 162 ( 9 5173 7.
36. + mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol 2003 33 ( 10 2801 10.
37. - regulatory T cells. Proc Natl Acad Sci USA 2002 99 ( 20 13031 6.
38. Zhang X Izikson L Liu L Weiner HL. Activation of CD25 (+) CD4 (+) regulatory T cells by oral antigen administration. J Immunol 2001 167 ( 8 4245 53.
39. + T cells mediating skin inflammation. Blood 2003 102 ( 9 3295 301.
40. + regulatory T cells and TGF-beta in oral tolerance. J Leukoc Biol 2005 77 ( 6 906 13.
41. + regulatory T cells. Nat Immunol 2003 4 ( 4 330 6.
42. Hori S Nomura T Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 61.
43. Khattri R Kasprowicz D Cox T Mortrud M Appleby MW Brunkow ME Ziegler SF Ramsdell F. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 2001 167 ( 11 6312 20.
44. Smith KM Davidson JM Garside P. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 2002 106 ( 2 144 58.
45. + T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J Exp Med 2005 201 ( 11 1815 23.